Larry Heaton

President, Chief Executive Officer & Director, Zomedica

Search every verified Larry Heaton interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Larry Heaton, CEO of Zomedica, has appeared in multiple investor-focused events in mid-2026, including a podcast with Water Tower Research and the company's "Fourth Friday at Four" webinar series. Heaton stated that Zomedica generated $8.8 million in revenue in the first quarter of 2026, a 35% year-over-year increase, and described it as the company's 21st consecutive quarter of record revenue growth. He noted that the first quarter has historically been the lowest seasonal period for revenue. Heaton said the company's priorities include accelerating global adoption of its portfolio, expanding recurring revenue streams, and progressing toward cash flow break-even and profitability, with a goal of achieving both in 2027. Heaton described Zomedica's "five pillars" as an operational framework that every product must pass before entering the portfolio, rather than a marketing tagline. He said the company has sufficient capital to achieve its objectives and would be "loathed" to add further dilution for shareholders. Heaton stated that the company will not deploy capital for a stock buyback until it is cash flow positive. He also commented that the company's share price is "below cash" despite increasing revenues, efficient manufacturing, and no debt, and he attributed the gap to market conditions and shareholder selling pressure. Heaton said Zomedica is considering options for relisting on a major exchange and is working toward that goal.